ARPA-H Funds Two Cancer "Manhattan Projects"

Area of Science:

• Biomedical Engineering
• Immunology
• Oncology

Background:

• Cancer research faces challenges in real-time monitoring and personalized treatment.
• Enhancing the body's immune response is crucial for treating cancers, autoimmune disorders, and infectious diseases.

Purpose of the Study:

• To fund innovative cancer research through major awards from ARPA-H.
• To develop a device for continuous cancer monitoring and adaptive immunotherapy.
• To explore novel methods for boosting immune system efficacy against diseases.

Main Methods:

• Implantation of a monitoring device for real-time cancer tracking and immunotherapy dose adjustment.
• Development of new strategies to augment the host immune system's response to therapeutic interventions.

Main Results:

• ARPA-H has announced significant funding for two distinct cancer research initiatives.
• One project focuses on creating an implantable device for dynamic patient monitoring and treatment.
• The second initiative aims to improve immune system engagement in disease therapy.

Conclusions:

• These ARPA-H funded projects represent significant advancements in cancer care and broader therapeutic strategies.
• The research holds promise for more effective, personalized treatments for a range of challenging health conditions.